Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

• Mitchel Tate,
• Mitchel Tate,
• Darnel Prakoso,
• Darnel Prakoso,
• Andrew M. Willis,
• Cheng Peng,
• Minh Deo,
• Cheng Xue Qin,
• Jesse L. Walsh,
• David M. Nash,
• Charles D. Cohen,
• Alex K. Rofe,
• Arpeeta Sharma,
• Helen Kiriazis,
• Daniel G. Donner,
• Judy B. De Haan,
• Anna M. D. Watson,
• Miles J. De Blasio,
• Miles J. De Blasio,
• Rebecca H. Ritchie,
• Rebecca H. Ritchie,
• Rebecca H. Ritchie

Affiliations

Mitchel Tate

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Mitchel Tate

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Darnel Prakoso

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Darnel Prakoso

School of Biosciences, The University of Melbourne, Melbourne, VIC, Australia

Andrew M. Willis

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Cheng Peng

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Minh Deo

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Cheng Xue Qin

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Jesse L. Walsh

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

David M. Nash

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Charles D. Cohen

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Alex K. Rofe

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Arpeeta Sharma

Oxidative Stress Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Helen Kiriazis

Preclinical Cardiology, Microsurgery and Imaging Platform, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Daniel G. Donner

Preclinical Cardiology, Microsurgery and Imaging Platform, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Judy B. De Haan

Oxidative Stress Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Anna M. D. Watson

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Miles J. De Blasio

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Miles J. De Blasio

School of Biosciences, The University of Melbourne, Melbourne, VIC, Australia

Rebecca H. Ritchie

Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia

Rebecca H. Ritchie

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Rebecca H. Ritchie

Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia